Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Polydeoxyribonucleotides may help with healing and anti-aging, but more research is needed.

Some gonadal hormone drugs can block filovirus entry into cells.

The new fluoroquinolone effectively fights certain bacteria.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Keratin peptides can change hair shape gently without harsh chemicals.

Post-drug syndromes are often overlooked, and better systems and education are needed to improve drug safety.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

The Potts-Guy model best predicts skin permeability for the tested drugs.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Collagen peptides may promote hair growth by activating certain genes in the skin.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

Old drugs are often used for new, different medical purposes in endocrine pharmacology.

Current drug safety systems fail to detect long-term side effects, needing improvements to protect health and trust.

Balancing lipophilicity and solubility is key for effective and safe ketorolac prodrugs.

New nanocarriers improve skin drug delivery with low toxicity at certain concentrations.

Integrating biological networks improves drug repurposing and ADR prediction.

Scientists made nanoparticles from human hair proteins to improve drug delivery.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.